Thursday, July 07, 2022 12:17:58 PM
EDISON, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) -- StrikeForce Technologies, Inc. (OTC PINK: SFOR), a US based company is excited to announce that the SEC qualified the Company’s Regulation A Tier II registration offering that will benefit our secure SafeVchat video conferencing and PrivacyLok products. The Company’s financial partner, Continuation Capital, Inc., the Company’s anchor investor, is committed (although there can be no guarantees) to funding the entire offering, but StrikeForce has also opened the offering up to current shareholders and any outside investors looking for an opportunity in the cyber security space. The Company’s Broker is at spencerclarke.com (212-446-6100).
Recent 5/10/22 filed 8K management lowered the exercise price on a previous grant of 50,000,000 options @$.05 to an exercise price of $.02. These options were issued to The Special Equities Opportunity Fund LLC and Gregory Castaldo for helping the company raise $5,000,000. The options granted were registered in a S-1 filed on 12/13/21. In addition to dropping the exercise price the company also issued an additional 50,000,000 options @$.05 with an anti-dilution clause to The Special Equities Opportunity Fund LLC and Gregory Castaldo. This caused the company’s shareholders further dilution while protecting the recipients of the new grant with an anti-dilution provision. The company is receiving $1,000,000 for the exercise of the registered options, and the recipient is making the profit in excess of the $.02 per share being sold. The volume in the StrikeForce stock has been high and in the market of penny stocks it would make sense that those shares are being sold in the market to fund the $1,000,000 exercise price and the profit on all shares sold over $.02 would go to the parties who exercised the options.
*****This transaction should have been a registered offering by the company to raise money and not disguised as a simple exercise of options.
Recent ZRFY News
- Partnership to Offer Enhanced Cybersecurity Solutions • AllPennyStocks.com • 05/22/2023 02:45:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM